nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A7—Fluorouracil—pancreatic cancer	0.342	0.567	CbGbCtD
Cefotaxime—SLC22A7—Docetaxel—pancreatic cancer	0.261	0.433	CbGbCtD
Cefotaxime—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00194	0.00489	CcSEcCtD
Cefotaxime—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00194	0.00489	CcSEcCtD
Cefotaxime—Renal failure—Sunitinib—pancreatic cancer	0.00192	0.00485	CcSEcCtD
Cefotaxime—Erythema multiforme—Erlotinib—pancreatic cancer	0.00192	0.00484	CcSEcCtD
Cefotaxime—Colitis—Docetaxel—pancreatic cancer	0.00191	0.00482	CcSEcCtD
Cefotaxime—Candida infection—Docetaxel—pancreatic cancer	0.0019	0.00479	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00183	0.00462	CcSEcCtD
Cefotaxime—Arrhythmia—Tamoxifen—pancreatic cancer	0.00183	0.00462	CcSEcCtD
Cefotaxime—Arrhythmia—Erlotinib—pancreatic cancer	0.00181	0.00457	CcSEcCtD
Cefotaxime—Haemoglobin—Sunitinib—pancreatic cancer	0.00176	0.00445	CcSEcCtD
Cefotaxime—Haemorrhage—Sunitinib—pancreatic cancer	0.00175	0.00443	CcSEcCtD
Cefotaxime—Hepatitis—Sunitinib—pancreatic cancer	0.00175	0.00443	CcSEcCtD
Cefotaxime—Bronchospasm—Gemcitabine—pancreatic cancer	0.00173	0.00437	CcSEcCtD
Cefotaxime—Eosinophilia—Fluorouracil—pancreatic cancer	0.00171	0.00432	CcSEcCtD
Cefotaxime—Neutropenia—Irinotecan—pancreatic cancer	0.00169	0.00426	CcSEcCtD
Cefotaxime—Erythema multiforme—Sunitinib—pancreatic cancer	0.00166	0.00419	CcSEcCtD
Cefotaxime—Neutropenia—Gemcitabine—pancreatic cancer	0.00164	0.00415	CcSEcCtD
Cefotaxime—Angioedema—Tamoxifen—pancreatic cancer	0.00163	0.00411	CcSEcCtD
Cefotaxime—Leukopenia—Tamoxifen—pancreatic cancer	0.0016	0.00403	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—pancreatic cancer	0.00159	0.00402	CcSEcCtD
Cefotaxime—Renal failure—Irinotecan—pancreatic cancer	0.00158	0.00399	CcSEcCtD
Cefotaxime—Jaundice—Irinotecan—pancreatic cancer	0.00157	0.00396	CcSEcCtD
Cefotaxime—Arrhythmia—Sunitinib—pancreatic cancer	0.00157	0.00396	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00156	0.00392	CcSEcCtD
Cefotaxime—Renal failure—Gemcitabine—pancreatic cancer	0.00154	0.00389	CcSEcCtD
Cefotaxime—Renal impairment—Docetaxel—pancreatic cancer	0.00152	0.00383	CcSEcCtD
Cefotaxime—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00151	0.00381	CcSEcCtD
Cefotaxime—Discomfort—Tamoxifen—pancreatic cancer	0.0015	0.00379	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—pancreatic cancer	0.00148	0.00372	CcSEcCtD
Cefotaxime—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00146	0.00369	CcSEcCtD
Cefotaxime—Haemoglobin—Irinotecan—pancreatic cancer	0.00145	0.00367	CcSEcCtD
Cefotaxime—Haemorrhage—Irinotecan—pancreatic cancer	0.00145	0.00365	CcSEcCtD
Cefotaxime—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00144	0.00363	CcSEcCtD
Cefotaxime—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00143	0.0036	CcSEcCtD
Cefotaxime—Shock—Erlotinib—pancreatic cancer	0.00142	0.00358	CcSEcCtD
Cefotaxime—Haemoglobin—Gemcitabine—pancreatic cancer	0.00142	0.00357	CcSEcCtD
Cefotaxime—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00141	0.00356	CcSEcCtD
Cefotaxime—Haemorrhage—Gemcitabine—pancreatic cancer	0.00141	0.00355	CcSEcCtD
Cefotaxime—Angioedema—Sunitinib—pancreatic cancer	0.0014	0.00352	CcSEcCtD
Cefotaxime—Haemoglobin—Fluorouracil—pancreatic cancer	0.00139	0.00351	CcSEcCtD
Cefotaxime—Haemorrhage—Fluorouracil—pancreatic cancer	0.00138	0.00349	CcSEcCtD
Cefotaxime—Leukopenia—Sunitinib—pancreatic cancer	0.00137	0.00345	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00134	0.00339	CcSEcCtD
Cefotaxime—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00133	0.00336	CcSEcCtD
Cefotaxime—Convulsion—Sunitinib—pancreatic cancer	0.00132	0.00334	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.0013	0.00328	CcSEcCtD
Cefotaxime—Arrhythmia—Irinotecan—pancreatic cancer	0.00129	0.00326	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—pancreatic cancer	0.00129	0.00325	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—pancreatic cancer	0.00128	0.00323	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—pancreatic cancer	0.00127	0.0032	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00126	0.00318	CcSEcCtD
Cefotaxime—Arrhythmia—Gemcitabine—pancreatic cancer	0.00126	0.00317	CcSEcCtD
Cefotaxime—Pain—Tamoxifen—pancreatic cancer	0.00124	0.00314	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00124	0.00313	CcSEcCtD
Cefotaxime—Arrhythmia—Fluorouracil—pancreatic cancer	0.00124	0.00312	CcSEcCtD
Cefotaxime—Pain—Erlotinib—pancreatic cancer	0.00123	0.00311	CcSEcCtD
Cefotaxime—Bronchospasm—Docetaxel—pancreatic cancer	0.00123	0.0031	CcSEcCtD
Cefotaxime—Shock—Sunitinib—pancreatic cancer	0.00123	0.00309	CcSEcCtD
Cefotaxime—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00122	0.00308	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—pancreatic cancer	0.00119	0.00301	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00119	0.003	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—pancreatic cancer	0.00119	0.00299	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00118	0.00297	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—pancreatic cancer	0.00117	0.00296	CcSEcCtD
Cefotaxime—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00117	0.00295	CcSEcCtD
Cefotaxime—Neutropenia—Docetaxel—pancreatic cancer	0.00117	0.00295	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00117	0.00294	CcSEcCtD
Cefotaxime—Urticaria—Tamoxifen—pancreatic cancer	0.00116	0.00292	CcSEcCtD
Cefotaxime—Abdominal pain—Tamoxifen—pancreatic cancer	0.00115	0.0029	CcSEcCtD
Cefotaxime—Abdominal pain—Erlotinib—pancreatic cancer	0.00114	0.00287	CcSEcCtD
Cefotaxime—Body temperature increased—Erlotinib—pancreatic cancer	0.00114	0.00287	CcSEcCtD
Cefotaxime—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00114	0.00287	CcSEcCtD
Cefotaxime—Malaise—Irinotecan—pancreatic cancer	0.00113	0.00286	CcSEcCtD
Cefotaxime—Leukopenia—Irinotecan—pancreatic cancer	0.00113	0.00284	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00111	0.00281	CcSEcCtD
Cefotaxime—Malaise—Gemcitabine—pancreatic cancer	0.00111	0.00279	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.0011	0.00278	CcSEcCtD
Cefotaxime—Leukopenia—Gemcitabine—pancreatic cancer	0.0011	0.00277	CcSEcCtD
Cefotaxime—Renal failure—Docetaxel—pancreatic cancer	0.00109	0.00276	CcSEcCtD
Cefotaxime—Jaundice—Docetaxel—pancreatic cancer	0.00108	0.00274	CcSEcCtD
Cefotaxime—Leukopenia—Fluorouracil—pancreatic cancer	0.00108	0.00272	CcSEcCtD
Cefotaxime—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00107	0.00271	CcSEcCtD
Cefotaxime—Pain—Sunitinib—pancreatic cancer	0.00107	0.00269	CcSEcCtD
Cefotaxime—Discomfort—Irinotecan—pancreatic cancer	0.00106	0.00267	CcSEcCtD
Cefotaxime—Convulsion—Fluorouracil—pancreatic cancer	0.00104	0.00263	CcSEcCtD
Cefotaxime—Agranulocytosis—Docetaxel—pancreatic cancer	0.00104	0.00262	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00103	0.0026	CcSEcCtD
Cefotaxime—Discomfort—Gemcitabine—pancreatic cancer	0.00103	0.0026	CcSEcCtD
Cefotaxime—Pruritus—Tamoxifen—pancreatic cancer	0.00103	0.0026	CcSEcCtD
Cefotaxime—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00103	0.00259	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—pancreatic cancer	0.00102	0.00258	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00102	0.00257	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00102	0.00257	CcSEcCtD
Cefotaxime—Pruritus—Erlotinib—pancreatic cancer	0.00102	0.00257	CcSEcCtD
Cefotaxime—Discomfort—Fluorouracil—pancreatic cancer	0.00101	0.00256	CcSEcCtD
Cefotaxime—Shock—Irinotecan—pancreatic cancer	0.00101	0.00255	CcSEcCtD
Cefotaxime—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00101	0.00254	CcSEcCtD
Cefotaxime—Haemoglobin—Docetaxel—pancreatic cancer	0.001	0.00253	CcSEcCtD
Cefotaxime—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.001	0.00252	CcSEcCtD
Cefotaxime—Haemorrhage—Docetaxel—pancreatic cancer	0.000999	0.00252	CcSEcCtD
Cefotaxime—Hepatitis—Docetaxel—pancreatic cancer	0.000999	0.00252	CcSEcCtD
Cefotaxime—Diarrhoea—Tamoxifen—pancreatic cancer	0.000996	0.00251	CcSEcCtD
Cefotaxime—Abdominal pain—Sunitinib—pancreatic cancer	0.000986	0.00249	CcSEcCtD
Cefotaxime—Body temperature increased—Sunitinib—pancreatic cancer	0.000986	0.00249	CcSEcCtD
Cefotaxime—Diarrhoea—Erlotinib—pancreatic cancer	0.000985	0.00249	CcSEcCtD
Cefotaxime—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000984	0.00248	CcSEcCtD
Cefotaxime—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000979	0.00247	CcSEcCtD
Cefotaxime—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000963	0.00243	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—pancreatic cancer	0.000947	0.00239	CcSEcCtD
Cefotaxime—Erythema multiforme—Docetaxel—pancreatic cancer	0.000945	0.00238	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000943	0.00238	CcSEcCtD
Cefotaxime—Vomiting—Tamoxifen—pancreatic cancer	0.000926	0.00234	CcSEcCtD
Cefotaxime—Hypersensitivity—Sunitinib—pancreatic cancer	0.000919	0.00232	CcSEcCtD
Cefotaxime—Rash—Tamoxifen—pancreatic cancer	0.000918	0.00232	CcSEcCtD
Cefotaxime—Dermatitis—Tamoxifen—pancreatic cancer	0.000917	0.00231	CcSEcCtD
Cefotaxime—Vomiting—Erlotinib—pancreatic cancer	0.000916	0.00231	CcSEcCtD
Cefotaxime—Headache—Tamoxifen—pancreatic cancer	0.000912	0.0023	CcSEcCtD
Cefotaxime—Rash—Erlotinib—pancreatic cancer	0.000908	0.00229	CcSEcCtD
Cefotaxime—Dermatitis—Erlotinib—pancreatic cancer	0.000907	0.00229	CcSEcCtD
Cefotaxime—Headache—Erlotinib—pancreatic cancer	0.000902	0.00228	CcSEcCtD
Cefotaxime—Arrhythmia—Docetaxel—pancreatic cancer	0.000893	0.00225	CcSEcCtD
Cefotaxime—Pruritus—Sunitinib—pancreatic cancer	0.000882	0.00223	CcSEcCtD
Cefotaxime—Pain—Irinotecan—pancreatic cancer	0.000878	0.00222	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000877	0.00221	CcSEcCtD
Cefotaxime—Nausea—Tamoxifen—pancreatic cancer	0.000865	0.00218	CcSEcCtD
Cefotaxime—Pain—Gemcitabine—pancreatic cancer	0.000855	0.00216	CcSEcCtD
Cefotaxime—Nausea—Erlotinib—pancreatic cancer	0.000855	0.00216	CcSEcCtD
Cefotaxime—Diarrhoea—Sunitinib—pancreatic cancer	0.000853	0.00215	CcSEcCtD
Cefotaxime—Feeling abnormal—Irinotecan—pancreatic cancer	0.000846	0.00214	CcSEcCtD
Cefotaxime—Pain—Fluorouracil—pancreatic cancer	0.000841	0.00212	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00084	0.00212	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—pancreatic cancer	0.000834	0.0021	CcSEcCtD
Cefotaxime—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000824	0.00208	CcSEcCtD
Cefotaxime—Abdominal pain—Irinotecan—pancreatic cancer	0.000812	0.00205	CcSEcCtD
Cefotaxime—Body temperature increased—Irinotecan—pancreatic cancer	0.000812	0.00205	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000812	0.00205	CcSEcCtD
Cefotaxime—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000811	0.00205	CcSEcCtD
Cefotaxime—Vomiting—Sunitinib—pancreatic cancer	0.000793	0.002	CcSEcCtD
Cefotaxime—Body temperature increased—Gemcitabine—pancreatic cancer	0.000791	0.002	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—pancreatic cancer	0.000787	0.00199	CcSEcCtD
Cefotaxime—Rash—Sunitinib—pancreatic cancer	0.000786	0.00198	CcSEcCtD
Cefotaxime—Dermatitis—Sunitinib—pancreatic cancer	0.000785	0.00198	CcSEcCtD
Cefotaxime—Urticaria—Fluorouracil—pancreatic cancer	0.000781	0.00197	CcSEcCtD
Cefotaxime—Headache—Sunitinib—pancreatic cancer	0.000781	0.00197	CcSEcCtD
Cefotaxime—Leukopenia—Docetaxel—pancreatic cancer	0.000779	0.00196	CcSEcCtD
Cefotaxime—Body temperature increased—Fluorouracil—pancreatic cancer	0.000778	0.00196	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—pancreatic cancer	0.000771	0.00195	CcSEcCtD
Cefotaxime—Hypersensitivity—Irinotecan—pancreatic cancer	0.000757	0.00191	CcSEcCtD
Cefotaxime—Convulsion—Docetaxel—pancreatic cancer	0.000754	0.0019	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000744	0.00188	CcSEcCtD
Cefotaxime—Nausea—Sunitinib—pancreatic cancer	0.000741	0.00187	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—pancreatic cancer	0.000738	0.00186	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—pancreatic cancer	0.000732	0.00185	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—pancreatic cancer	0.000729	0.00184	CcSEcCtD
Cefotaxime—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000725	0.00183	CcSEcCtD
Cefotaxime—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00071	0.00179	CcSEcCtD
Cefotaxime—Pruritus—Gemcitabine—pancreatic cancer	0.000708	0.00179	CcSEcCtD
Cefotaxime—Diarrhoea—Irinotecan—pancreatic cancer	0.000703	0.00177	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—pancreatic cancer	0.000701	0.00177	CcSEcCtD
Cefotaxime—Shock—Docetaxel—pancreatic cancer	0.000698	0.00176	CcSEcCtD
Cefotaxime—Pruritus—Fluorouracil—pancreatic cancer	0.000696	0.00176	CcSEcCtD
Cefotaxime—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000695	0.00175	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000689	0.00174	CcSEcCtD
Cefotaxime—Diarrhoea—Gemcitabine—pancreatic cancer	0.000684	0.00173	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—pancreatic cancer	0.000683	0.00172	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—pancreatic cancer	0.000677	0.00171	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—pancreatic cancer	0.000677	0.00171	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—pancreatic cancer	0.000674	0.0017	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—pancreatic cancer	0.000674	0.0017	CcSEcCtD
Cefotaxime—Diarrhoea—Fluorouracil—pancreatic cancer	0.000673	0.0017	CcSEcCtD
Cefotaxime—Vomiting—Irinotecan—pancreatic cancer	0.000653	0.00165	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000648	0.00164	CcSEcCtD
Cefotaxime—Rash—Irinotecan—pancreatic cancer	0.000648	0.00163	CcSEcCtD
Cefotaxime—Dermatitis—Irinotecan—pancreatic cancer	0.000647	0.00163	CcSEcCtD
Cefotaxime—Headache—Irinotecan—pancreatic cancer	0.000643	0.00162	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—pancreatic cancer	0.000637	0.00161	CcSEcCtD
Cefotaxime—Vomiting—Gemcitabine—pancreatic cancer	0.000636	0.0016	CcSEcCtD
Cefotaxime—Rash—Gemcitabine—pancreatic cancer	0.000631	0.00159	CcSEcCtD
Cefotaxime—Dermatitis—Gemcitabine—pancreatic cancer	0.00063	0.00159	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—pancreatic cancer	0.000627	0.00158	CcSEcCtD
Cefotaxime—Headache—Gemcitabine—pancreatic cancer	0.000627	0.00158	CcSEcCtD
Cefotaxime—Vomiting—Fluorouracil—pancreatic cancer	0.000625	0.00158	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—pancreatic cancer	0.000624	0.00157	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—pancreatic cancer	0.000624	0.00157	CcSEcCtD
Cefotaxime—Rash—Fluorouracil—pancreatic cancer	0.00062	0.00156	CcSEcCtD
Cefotaxime—Dermatitis—Fluorouracil—pancreatic cancer	0.00062	0.00156	CcSEcCtD
Cefotaxime—Headache—Fluorouracil—pancreatic cancer	0.000616	0.00155	CcSEcCtD
Cefotaxime—Nausea—Irinotecan—pancreatic cancer	0.00061	0.00154	CcSEcCtD
Cefotaxime—Pain—Docetaxel—pancreatic cancer	0.000607	0.00153	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—pancreatic cancer	0.000602	0.00152	CcSEcCtD
Cefotaxime—Nausea—Gemcitabine—pancreatic cancer	0.000594	0.0015	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00059	0.00149	CcSEcCtD
Cefotaxime—Feeling abnormal—Docetaxel—pancreatic cancer	0.000585	0.00148	CcSEcCtD
Cefotaxime—Nausea—Fluorouracil—pancreatic cancer	0.000584	0.00147	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000581	0.00146	CcSEcCtD
Cefotaxime—Body temperature increased—Docetaxel—pancreatic cancer	0.000561	0.00142	CcSEcCtD
Cefotaxime—Abdominal pain—Docetaxel—pancreatic cancer	0.000561	0.00142	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—pancreatic cancer	0.000557	0.00141	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000544	0.00137	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—pancreatic cancer	0.000529	0.00133	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—pancreatic cancer	0.000525	0.00133	CcSEcCtD
Cefotaxime—Hypersensitivity—Docetaxel—pancreatic cancer	0.000523	0.00132	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—pancreatic cancer	0.000508	0.00128	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000504	0.00127	CcSEcCtD
Cefotaxime—Pruritus—Docetaxel—pancreatic cancer	0.000502	0.00127	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—pancreatic cancer	0.000494	0.00125	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—pancreatic cancer	0.00049	0.00124	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—pancreatic cancer	0.000486	0.00123	CcSEcCtD
Cefotaxime—Diarrhoea—Docetaxel—pancreatic cancer	0.000486	0.00123	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000479	0.00121	CcSEcCtD
Cefotaxime—Shock—Epirubicin—pancreatic cancer	0.000471	0.00119	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—pancreatic cancer	0.00047	0.00119	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000469	0.00118	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—pancreatic cancer	0.000457	0.00115	CcSEcCtD
Cefotaxime—Vomiting—Docetaxel—pancreatic cancer	0.000451	0.00114	CcSEcCtD
Cefotaxime—Rash—Docetaxel—pancreatic cancer	0.000448	0.00113	CcSEcCtD
Cefotaxime—Dermatitis—Docetaxel—pancreatic cancer	0.000447	0.00113	CcSEcCtD
Cefotaxime—Headache—Docetaxel—pancreatic cancer	0.000445	0.00112	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000443	0.00112	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—pancreatic cancer	0.000436	0.0011	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000434	0.00109	CcSEcCtD
Cefotaxime—Nausea—Docetaxel—pancreatic cancer	0.000422	0.00106	CcSEcCtD
Cefotaxime—Pain—Epirubicin—pancreatic cancer	0.000409	0.00103	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—pancreatic cancer	0.000395	0.000996	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000392	0.000988	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—pancreatic cancer	0.00038	0.00096	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—pancreatic cancer	0.000379	0.000956	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—pancreatic cancer	0.000379	0.000955	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—pancreatic cancer	0.000379	0.000955	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000365	0.000921	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000362	0.000914	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—pancreatic cancer	0.000353	0.00089	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—pancreatic cancer	0.000352	0.000888	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—pancreatic cancer	0.00035	0.000884	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—pancreatic cancer	0.00035	0.000884	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—pancreatic cancer	0.000339	0.000855	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—pancreatic cancer	0.000328	0.000827	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000326	0.000824	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—pancreatic cancer	0.000313	0.000791	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—pancreatic cancer	0.000304	0.000768	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—pancreatic cancer	0.000303	0.000765	CcSEcCtD
Cefotaxime—Rash—Epirubicin—pancreatic cancer	0.000302	0.000762	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—pancreatic cancer	0.000302	0.000761	CcSEcCtD
Cefotaxime—Headache—Epirubicin—pancreatic cancer	0.0003	0.000757	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—pancreatic cancer	0.000284	0.000718	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—pancreatic cancer	0.000282	0.000711	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—pancreatic cancer	0.000279	0.000705	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—pancreatic cancer	0.000279	0.000704	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—pancreatic cancer	0.000278	0.0007	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—pancreatic cancer	0.000263	0.000664	CcSEcCtD
